Paul Milligan BSc MSc PhD
- Room 411a
- LSHTM
- Keppel Street
- London
- WC1E 7HT
- T: +44(0)207 927 2126
- F: +44(0)207 636 8739
I joined the School in August 2004, before that I worked for 8 years in the MRC Laboratories in The Gambia, and before that at the Liverpool School of Tropical Medicine.
Affiliation
Teaching
I organise the distance learning study module in Communicable Disease Epidemiology. I also contribute to teaching overseas, currently I am organiser of a clinical trials training programme in Western China funded by DFID.
Research
Current projects include evaluation of seasonal drug administration to prevent morbidity and mortality from malaria in Senegal. I am interested in design and analysis issues in malaria intervention trials, and in cluster sampling methods for health surveys in developing countries.
Research areas
- Child health
- Clinical trials
- Public health
Disciplines
- Epidemiology
- Statistics
Disease and Health Conditions
- Infectious disease
- Malaria
Other interests
- Health Surveys
- MARCH
-
Selected publications
-
A Simple Approach to the Estimation of Incidence Rate Difference
Xu, T; Lam, E; Milligan, PJM; Cheung, Y;
American Journal of Epidemiology, In Press;
-
Estimation of intervention effects using first or multiple episodes in clinical trials: The Andersen-Gill model re-examined
Cheung, Y.B.; Xu, Y.; Tan, S.H.; Cutts, F.; Milligan, P.
Statistics in Medicine, 2010; 29(3):328-336
-
Amodiaquine dosage and tolerability for intermittent preventive treatment to prevent malaria in children.
Cairns, M.; Cisse, B.; Sokhna, C.; Cames, C.; Simondon, K.; Ba, E.H.; Trape, J.F.; Gaye, O.; Greenwood, B.M.; Milligan, P.J.;
Antimicrob Agents Chemother, 2010;
-
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon
Mordmuller, B.; Szywon, K.; Greutelaers, B.; Esen, M.; Mewono, L.; Treut, C.; Murbeth, R.E.; Chilengi, R.; Noor, R.; Kilama, W.L.; Imoukhuede, E.B.; Imbault, N.; Leroy, O.; Theisen, M.; Jepsen, S.; Milligan, P.; Fendel, R.; Kremsner, P.G.; Issifou, S.
Vaccine, 2010; 28(41):6698-6703
-
Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
Cisse, B.; Cairns, M.; Faye, E.; NDiaye, O.; Faye, B.; Cames, C.; Cheng, Y.; NDiaye, M.; L?, A.C.; Simondon, K.; Trape, J.F.; Faye, O.; NDiaye, J.L.; Gaye, O.; Greenwood, B.; Milligan, P.;
PLoS One, 2009; 4(9):e7164
-
Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia
Bojang, K.; Milligan, P.; Pinder, M.; Doherty, T.; Leach, A.; Ofori-Anyinam, O.; Lievens, M.; Kester, K.; Schaecher, K.; Ballou, W.R.; Cohen, J.
Human Vaccines, 2009; 5(4):242-247
-
Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
Adegbola, R.A.; Secka, O.; Lahai, G.; Lloyd-Evans, N.; Njie, A.; Usen, S.; Oluwalana, C.; Obaro, S.; Weber, M.; Corrah, T.; Mulholland, K.; McAdam, K.; Greenwood, B.; Milligan, P.J.;
Lancet, 2005; 366(9480):144-50
-
Comparison of two cluster sampling methods for health surveys in developing countries
Milligan, P.; Njie, A.; Bennett, S.
International Journal of Epidemiology, 2004; 33(3):469
- → View all Paul Milligan's publications
